BioCentury | Jan 6, 2014
Company News

Ocera, Genentech, Roche deal

...the MATCH technology, is part of the company's streamlining activities following its merger with the Terrapin...
BioCentury | Sep 30, 2013
Company News

Ocera hepatic news

...which Ocera retains full rights. Ocera acquired the research facility through its merger with the Terrapin...
BioCentury | Aug 5, 2013
Financial News

EnteroMedics financial update

...shares. Canaccord Genuity is the sales agent. The program replaces a $45 million facility with Terrapin...
BioCentury | Jul 22, 2013
Company News

Ocera, Tranzyme deal

...Diego, Calif. Tranzyme Inc. , Durham, N.C. Business: Hepatic Ocera completed its merger with Tranzyme's Terrapin...
BioCentury | Jul 22, 2013
Financial News

Ocera completes private placement

...The offering was concurrent with the merger of privately owned Ocera Therapeutics Inc. with the Terrapin...
BioCentury | May 13, 2013
Company News

Ocera, Tranzyme deal

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...
BioCentury | May 13, 2013
Company News

Ocera, Tranzyme deal

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...
BioCentury | May 13, 2013
Company News

Ocera, Tranzyme deal

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...
BioCentury | Apr 15, 2013
Company News

Terrapin, Sanwa Kagaku Kenkyusho Co. Ltd. deal

...Terrapin and Sanwa will use Terrapin's TRAP molecular fingerprinting technology to develop compounds to treat diabetes...
...active substances that lower blood glucose through their action on the insulin signal transduction pathway. Terrapin...
...investments, and is eligible for royalties. Sanwa receives commercialization rights in Japan and Asia, while Terrapin...
BioCentury | Apr 15, 2013
Company News

Terrapin, Taiho deal

...the development of Terrapin's TER286 broad spectrum cancer compound. Taiho will provide R&D funding and Terrapin...
...to an IND, Taiho could obtain commercialization rights in Japan and possibly other Asian countries. Terrapin...
...a certain glutathione S-transferase (GST-P1) enzyme present in elevated amounts in many resistant solid tumors. Terrapin Technologies Inc....
Items per page:
1 - 10 of 24
BioCentury | Jan 6, 2014
Company News

Ocera, Genentech, Roche deal

...the MATCH technology, is part of the company's streamlining activities following its merger with the Terrapin...
BioCentury | Sep 30, 2013
Company News

Ocera hepatic news

...which Ocera retains full rights. Ocera acquired the research facility through its merger with the Terrapin...
BioCentury | Aug 5, 2013
Financial News

EnteroMedics financial update

...shares. Canaccord Genuity is the sales agent. The program replaces a $45 million facility with Terrapin...
BioCentury | Jul 22, 2013
Company News

Ocera, Tranzyme deal

...Diego, Calif. Tranzyme Inc. , Durham, N.C. Business: Hepatic Ocera completed its merger with Tranzyme's Terrapin...
BioCentury | Jul 22, 2013
Financial News

Ocera completes private placement

...The offering was concurrent with the merger of privately owned Ocera Therapeutics Inc. with the Terrapin...
BioCentury | May 13, 2013
Company News

Ocera, Tranzyme deal

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...
BioCentury | May 13, 2013
Company News

Ocera, Tranzyme deal

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...
BioCentury | May 13, 2013
Company News

Ocera, Tranzyme deal

...Tranzyme and Ocera said that Ocera will merge with Tranzyme's Terrapin Acquisition Inc. subsidiary in a...
BioCentury | Apr 15, 2013
Company News

Terrapin, Sanwa Kagaku Kenkyusho Co. Ltd. deal

...Terrapin and Sanwa will use Terrapin's TRAP molecular fingerprinting technology to develop compounds to treat diabetes...
...active substances that lower blood glucose through their action on the insulin signal transduction pathway. Terrapin...
...investments, and is eligible for royalties. Sanwa receives commercialization rights in Japan and Asia, while Terrapin...
BioCentury | Apr 15, 2013
Company News

Terrapin, Taiho deal

...the development of Terrapin's TER286 broad spectrum cancer compound. Taiho will provide R&D funding and Terrapin...
...to an IND, Taiho could obtain commercialization rights in Japan and possibly other Asian countries. Terrapin...
...a certain glutathione S-transferase (GST-P1) enzyme present in elevated amounts in many resistant solid tumors. Terrapin Technologies Inc....
Items per page:
1 - 10 of 24